This inventor holds 1 USPTO granted patent. Top assignees: Aleta Biotherapeutics Inc., Regents of the University of Minnesota. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 8 
1 out of 2,373 
Years Active: 2024
Title: The Innovations of Justin Klesmith
Introduction
Justin Klesmith is an accomplished inventor based in Roseville, Minnesota. He has made significant contributions to the field of biotechnology, particularly in the area of cancer treatment. His work focuses on the development of CD19 variants, which have the potential to revolutionize therapeutic approaches for cancer patients.
Latest Patents
Justin Klesmith holds one patent related to CD19 variants. This patent describes methods of identifying CD19 variants and outlines various applications for these variants, especially in treating cancer. His innovative approach aims to enhance the effectiveness of cancer therapies.
Career Highlights
Throughout his career, Justin has worked with notable organizations, including Aleta Biotherapeutics Inc. and the University of Minnesota. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Justin's coworkers include Roy R. Lobb and Paul David Rennert. Their collaborative efforts have further advanced the research and development of innovative cancer treatments.
Conclusion
Justin Klesmith's work exemplifies the impact of innovation in biotechnology. His contributions to the development of CD19 variants highlight the potential for new cancer therapies. His dedication to research and collaboration continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile